in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza on Track to Meet 2012 Targets; Arch Integration Progressing Well
11:21 AM MDT | May 4, 2012 | Deepti Ramesh
Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with expectations in the quarter. Capacity utilization was at good levels across all its business units and there has been a growth in project pipelines in its key business areas, the company says. Lonza acquired biocides maker Arch Chemicals (Norwalk, CT) for $1.4 billion last October, and the integration of Arch is proceeding as planned and the order intake was in line with expectations, Lonza says. Lonza is on track to meet...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee